SUBLEASESublease • May 9th, 2023 • CytomX Therapeutics, Inc. • Pharmaceutical preparations
Contract Type FiledMay 9th, 2023 Company IndustryTHIS SUBLEASE (this “Sublease”) is dated for reference purposes as of March 24, 2023, and is made by and between CytomX Therapeutics, Inc., a Delaware corporation (“Sublessor”), and Atomic AI, Inc., a Delaware corporation (“Sublessee”). Sublessor and Sublessee hereby agree as follows: